Analyzing Real-World Evidence on the Usage of GLP-1 Class Drugs, Regarding Efficacy and Adherence
Time: 11:15 am
day: Conference Day Two
Details:
- Leveraging Real-World Evidence of the usage of GLP-1 Class drugs on patient behaviors, experience and adherence patterns
- Sharing progress and lessons learned from marketed anti-obesity drugs
- Exploring new therapeutic directions and future precision medicine for anti-obesity drugs
